Free Treatment For Metastatic Breast Cancer Patients Willing to Join Randomized Phase 3 Trial

We at Dharamshila Cancer Hospital and Research Centre have initiated a Clinical Research Study with the approval of our Institutional Ethics Committee and also by Drug Controller of India. This study targets women with Her2+ Metastatic Breast Cancer who are above 18 years of age, do not have any clinical or radiological evidence of sever/uncontrolled cardiovascular disease and have not received prior chemotherapy for metastatic breast cancer. To be eligible for the trial, the patients should have no brain metastasis. The patients will be given free treatment as per protocol along with travel allowances.

The trial is called BEAT MBC. It is a multicentric trial presently running across 20 centers in India. More than 50 patients have already been enrolled in this trial and the target is to randomize 200 patients.

Cancer knows no boundaries of gender, race or age. Cancer knows no limits; neither should you when it comes to finding out treatment options for your patients. Scientific advances that may be used in years ahead to prevent, diagnose or treat cancer are available today by those participating in carefully controlled clinical trials. Because of the advances in cancer research, we have improved our ability to prevent, detect and treat cancer. Every day cancer clinical trials are bringing us one step closer to making that vision a reality. There are more new treatments and new drugs available to cancer patients today, than ever before. Many people who have had cancer live longer and enjoy a better quality of life than was possible thirty years ago. Clinical trials are the necessary link between cancer research and improved treatment options for patients. The introduction of new molecules into clinical trials resulted in a doubling of survival for cancer patients compared to the older treatment.

Clinical trials are not just a vital source of information; they can be of great value to the individuals who participate in them. In the majority of trials, participants receive either the best existing treatment (also called the standard of care), or the new therapy. By investigating clinical trial options, patients can learn what the best available standard of care is for their disease .When one participates in a trial, in addition to receiving quality treatment at no cost; one gets the opportunity to undergo all the investigations which sometimes are unaffordable. If your patient has been diagnosed with cancer, we hope that the information presented here is the beginning of a quest to get informed about their treatment options.

Breast cancer accounts for over one third of invasive cancers in women. Every year 180,000 women are diagnosed of breast cancer and 44000 die of the disease without treatment. Although more and more people are becoming aware of the fact that breast cancer is a significant concern for women across the population, many fail to follow a proper treatment regime either because of the scarcity of resources or due to the lack of accurate information and thus are prone to face the consequences.